Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,006 | -1,785 | -9,467 | -7,371 | -5,154 |
| Depreciation Amortization | 266 | 133 | 744 | 583 | 392 |
| Accounts payable and accrued liabilities | -133 | 22 | 184 | 70 | 22 |
| Other Working Capital | -151 | 8 | 21 | -160 | -136 |
| Other Operating Activity | 380 | 28 | 40 | 102 | 91 |
| Operating Cash Flow | $-3,644 | $-1,594 | $-8,479 | $-6,777 | $-4,786 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -84 | -84 | -57 | -47 | -47 |
| Investing Cash Flow | $-84 | $-84 | $-57 | $-47 | $-47 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,320 | 1,245 | 5,296 | 4,568 | 3,993 |
| Financing Cash Flow | $7,320 | $1,245 | $5,296 | $4,568 | $3,993 |
| Beginning Cash Position | 1,559 | 1,559 | 4,798 | 4,798 | 4,798 |
| End Cash Position | 5,151 | 1,126 | 1,559 | 2,543 | 3,958 |
| Net Cash Flow | $3,592 | $-433 | $-3,239 | $-2,255 | $-840 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,644 | -1,594 | -8,479 | -6,777 | -4,786 |
| Capital Expenditure | -84 | -84 | -57 | -47 | -47 |
| Free Cash Flow | -3,728 | -1,678 | -8,536 | -6,824 | -4,833 |